The estimated Net Worth of Peter J. Thornton is at least $1.13 Million dollars as of 27 May 2022. Peter Thornton owns over 50,000 units of Avadel Pharmaceuticals plc stock worth over $1,133,701 and over the last 20 years Peter sold AVDL stock worth over $0.
Peter has made over 2 trades of the Avadel Pharmaceuticals plc stock since 2017, according to the Form 4 filled with the SEC. Most recently Peter bought 50,000 units of AVDL stock worth $84,500 on 27 May 2022.
The largest trade Peter's ever made was buying 50,000 units of Avadel Pharmaceuticals plc stock on 27 May 2022 worth over $84,500. On average, Peter trades about 3,244 units every 101 days since 2004. As of 27 May 2022 Peter still owns at least 83,055 units of Avadel Pharmaceuticals plc stock.
You can see the complete history of Peter Thornton stock trades at the bottom of the page.
Peter's mailing address filed with the SEC is C/O AVADEL PHARMACEUTICALS PLC, 10 EARLSFORT TERRACE, DUBLIN 2, L2, D02 T380.
Over the last 8 years, insiders at Avadel Pharmaceuticals plc have traded over $7,791,038 worth of Avadel Pharmaceuticals plc stock and bought 775,568 units worth $4,366,224 . The most active insiders traders include Healthcare Master Fund Ltd ..., Kevin Broadfin Capital, Llc..., and Naseem Amin. On average, Avadel Pharmaceuticals plc executives and independent directors trade stock every 43 days with the average trade being worth of $381,436. The most recent stock trade was executed by Thomas S Mchugh on 16 January 2024, trading 2,000 units of AVDL stock currently worth $29,000.
avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.
Avadel Pharmaceuticals plc executives and other stock owners filed with the SEC include: